Recursos del Paciente
Manténgase sano!
Resultados de su búsqueda "ALS (Lou Gehrig's Disease)".
Resultados de noticias de salud - 35
Genetics Suggest Link Between ALS, Parkinson's Disease
- Dennis Thompson HealthDay Reporter
- September 16, 2024
- Página completa
People with rare genetic variants linked to degenerative brain disorders like Parkinson’s disease are at increased risk of developing ALS, a new study finds.
Further, having these ...
Brain-Computer Combo Lets Mute Man With ALS 'Talk' Again
- Dennis Thompson HealthDay Reporter
- August 15, 2024
- Página completa
Casey Harrell was losing his ability to speak due to amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
“Not being able to communicate is so frustrating and demoralizing. It is like you are trapped,†said Harrell, 45.
But a ...
Staying Fit Might Cut Men's Odds for ALS
- Carole Tanzer Miller HealthDay Reporter
- June 27, 2024
- Página completa
The search for a cure for ALS has been elusive, but researchers may have identified a way to lower a man's risk in the long run.
Staying fit and getting moderate levels of exercise may lower the chances for
Surgery Helps Young Kids With Cerebral Palsy Walk, Regardless of Age
- Carole Tanzer Miller HealthDay Reporter
- June 21, 2024
- Página completa
A surgery that helps 7- to 10-year-olds with cerebral palsy walk also helps older kids and teens with the condition, a groundbreaking study shows.
"We had thought that the older kids would not do as well, but there was really no difference in outcomes between the two gro...
Chemicals Stored in Your Garage Could Raise Odds for ALS
- Dennis Thompson HealthDay Reporter
- April 15, 2024
- Página completa
Volatile and toxic chemicals commonly stored in garages can increase the risk of amyotrophic lateral sclerosis (ALS).
Gasoline or kerosene, gas-powered equipment and lawn care chemicals represented the top three risk factors for ALS found in garages, researchers report.<...
Maker Is Pulling Controversial ALS Drug Relyvrio Off the Market
- Ernie Mundell HealthDay Reporter
- April 4, 2024
- Página completa
THURSDAY, April 4, 2024 (HealthDayNews) -- Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market.
Poor Trial Results May Prompt Maker to Pull ALS Drug From Market
- Robin Foster HealthDay Reporter
- March 11, 2024
- Página completa
Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.
In a statement...
Elon Musk Says First Human Has Received Neuralink Brain Implant
- Robin Foster HealthDay Reporter
- January 31, 2024
- Página completa
Elon Musk, co-founder of Neuralink, said this week that the company placed the first brain implant in a human over the weekend.
In a statement posted on X, the platform former...
Study Confirms Link Between Smoking and ALS
- Ernie Mundell HealthDay Reporter
- January 30, 2024
- Página completa
New research is helping confirm smoking as a risk factor for the devastating brain illness amyotrophic lateral sclerosis (ALS).
ALS affects roughly 31,000 Americans each year, with about 5,000 new cases diagnosed annually, according to the U.S. Centers for Disease Contro...
Blood Test Measures ALS Risk From Environmental Toxins
- Cara Murez HealthDay Reporter
- November 1, 2023
- Página completa
Amyotrophic lateral sclerosis, better known as ALS, is debilitating and has no cure.
Now, researchers at the University of Michigan have developed an environmental risk score that will allow them to assess a person's risk for developing ALS, as well as their survival aft...
FDA Panel Says No to Experimental ALS Drug
- Cara Murez HealthDay Reporter
- September 28, 2023
- Página completa
An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for ALS.
Although the FDA isn't bound by the votes of its advisory panels, agency scientists have already penned a sca...
Across America, Many Who Need a Neurologist Live Too Far From Care
- Cara Murez HealthDay Reporter
- September 14, 2023
- Página completa
Many Medicare patients can't get help close to home for brain and nervous system issues.
Nearly 1 in 5 Medicare recipients in the United States live at least 50 miles from their neurologist.
"Our study found a substantial travel burden exists for some people with n...
ALS Robbed Her of Speech, But Technology Is Changing That
- Dennis Thompson HealthDay Reporter
- August 23, 2023
- Página completa
Many people with Lou Gehrig's disease, also called amyotrophic lateral sclerosis (ALS), first start to lose the ability to move their arms and legs.
That's not Pat Bennett. She can move just fine. She can still dress herself, and she can even use her fingers to type.
...
Could Dentures Raise Your Odds for Pneumonia?
- Steven Reinberg HealthDay Reporter
- June 26, 2023
- Página completa
Dentures may hide harmful germs that cause pneumonia, British researchers report.
For the study, the investigators took samples from the dentures of nursing home patients who did and didn't have pneumonia. They analyzed the samples to identify the types of microbes pres...
Diet Heavy in Omega-3s Might Help Slow ALS
- Cara Murez HealthDay Reporter
- June 22, 2023
- Página completa
Consuming omega-3 fatty acids like flaxseed oil and walnuts may help slow the decline in physical function related to amyotrophic lateral sclerosis (ALS), new research suggests.
ALS (formerly known as Lou Gehrig's disease) is a progressive neurodegenerative disease that ...
FDA Approves Drug for Rare Form of ALS
- Cara Murez HealthDay Reporter
- April 26, 2023
- Página completa
The U.S. Food and Drug Administration on Tuesday approved a new drug for people who have a rare, inherited type of...
People With Cerebral Palsy Could Be in the Crosshairs of the Opioid Crisis
- Cara Murez HealthDay Reporter
- April 25, 2023
- Página completa
People with cerebral palsy are more likely to be prescribed opioids to manage pain, making them vulnerable to the ongoing opioid crisis in the United States, according to a new study.
While pain is common among patients with cerebral palsy, opioids may not be as helpful ...
Roberta Flack Has ALS, Can No Longer Sing
- Robin Foster and Cara Murez HealthDay Reporters
- November 15, 2022
- Página completa
Singer Roberta Flack has the incurable disease ALS and can't sing, but she plans to stay active on other projects, her manager said Monday.
Flack, 85, is a Grammy winner best known for hits that include "Killing Me Softly With His Song"and "The First Time Ever I Saw You...
Cellular 'Fix' Treatment Shows Promise Against ALS in Small Study
- Amy Norton HealthDay Reporter
- October 20, 2022
- Página completa
Researchers have made early progress toward a new approach to treating the deadly brain disease amyotrophic lateral sclerosis (ALS): using patients' own immune system T cells.
FDA Approves New ALS Drug Despite Uncertain Data
- Ernie Mundell HealthDay Reporter
- September 30, 2022
- Página completa
The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for
Study Points to Jobs With Highest Risk for ALS
- By Cara Murez HealthDay Reporter
- September 26, 2022
- Página completa
People who work in manufacturing, welding and chemical operations and are exposed to hazardous chemicals may face a higher risk of developing amyotrophic lateral sclerosis (ALS...
Hints That Experimental Drug Might Curb a Form of ALS
- By Cara Murez HealthDay Reporter
- September 23, 2022
- Página completa
People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows.
The medication, tofersen, benefited patients with mutations of the gene SOD1. These mutations create a misfolded version of a protein, which leads to
In Rare Move, FDA Panel Gives Support to Controversial ALS Drug in 2nd Review
- Ernie Mundell HealthDay Reporter
- September 8, 2022
- Página completa
In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for
Blood Test Shows Promise for Quick Diagnosis of ALS
- By Cara Murez HealthDay Reporter
- September 7, 2022
- Página completa
Patients suspected of having amyotrophic lateral sclerosis (ALS) may soon be abl...
FDA Panel Skeptical of Controversial ALS Drug Ahead of Vote
- Cara Murez HealthDay Reporter
- September 6, 2022
- Página completa
A U.S. Food and Drug Administration panel will once again consider approval for an experimental drug for
New ALS Drug Approved in Canada While Still Under FDA Review
- By Robert Preidt HealthDay Reporter
- June 13, 2022
- Página completa
An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the t...
Do Dentures Take a Toll on Good Nutrition?
- By Robert Preidt HealthDay Reporter
- April 26, 2022
- Página completa
Dentures may take a bite out of your nutrition, a new study warns.
"They do not provide the same chewing efficiency, which may alter eating habits," said senior author Dr. Thankam Thyvalikakath, director of the Regenstrief Institute and the School of Dentistry Dental Inf...
FDA Advisory Panel Narrowly Votes Against New ALS Drug
- Dennis Thompson and Robin Foster
- March 31, 2022
- Página completa
In a close vote, an advisory panel for the U.S. Food and Drug Administration decided not to recommend the approval of an experimental drug for the deadly neurological disease amyotrophic lateral sclerosis (
Computer Helps 'Locked-In' ALS Patients Communicate, Shop Online
- Dennis Thompson
- March 30, 2022
- Página completa
A handful of "locked-in" amyotrophic lateral sclerosis (ALS) patients can now work a laptop computer using their brain waves, thanks to an implant lodged in a major vein inside their skull.
T...
FDA Reviewers Give Thumbs Down to New ALS Drug
- Dennis Thompson and Robin Foster
- March 29, 2022
- Página completa
Despite months of intense lobbying by patient advocates, federal health officials on Monday posted a largely negative review of an experimental drug for the devastating illness known as amyotrophic lateral sclerosis (ALS).
Stakes Are High Ahead of FDA Panel Vote on ALS Drug
- Dennis Thompson
- March 28, 2022
- Página completa
Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.
Out-of-Network Costs Raise Medical Bills for Special Needs Kids
- By Robert Preidt HealthDay Reporter
- March 28, 2022
- Página completa
Special needs children often require out-of-network care from specialists, which means more out-of-pocket costs and extra stress for families, a new study finds.
"In the U.S., the reality is that the more health care needs you have, especially from specialists, the great...
Brain Implant Helps Completely 'Locked-In' Man Communicate
- Dennis Thompson HealthDay Reporter
- March 22, 2022
- Página completa
Unable to move a single muscle, even to open your eyes. Completely locked into your own body, yet fully conscious and aware.
NFL Players Face 4 Times the Odds of ALS
- Denise Mann HealthDay Reporter
- December 16, 2021
- Página completa
NFL players are four times more likely to die of Lou Gehrig's disease (ALS) than other people, new research finds, adding to known links between football-related head injuries and brain diseases, including Alzheimer's, Parkinson's and chronic traumatic encephalopathy (CTE).
Are Avid Exercisers at Higher Risk for ALS?
- Alan Mozes HealthDay Reporter
- October 21, 2021
- Página completa
A new study may allay concerns that strenuous exercise could up the risk for developing amyotrophic lateral sclerosis (ALS), an incurable neurological disease.
No evidence of rising ALS risk was seen among adults who routinely work up a sweat by playing team sports or en...